Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

Published 2016 View Full Article

Authors

Keywords

Journal

LANCET

Volume 387, Issue 10024, Pages 1178-1186

Publisher

Elsevier BV

Online

2016-01-21

DOI

10.1016/s0140-6736(16)00082-9

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started